{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:48:30Z","timestamp":1793533710145,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Orthop Relat Res"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hip arthroplasty is often indicated in metastatic bone lesions of the proximal femur, with or without pathologic fracture. Conventional knowledge is that cemented fixation is best, although uncemented fixation has potential advantages of shorter operative time, avoidance of the physiologic stress of cement, and the chance for osseointegration. However, both techniques are options that are employed, and there is no clear evidence to guide this choice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Questions\/purposes<\/jats:title>\n            <jats:p>In patients with proximal femoral metastatic bone lesions who were carefully selected either to receive cemented or uncemented fixation based on patient age, bone quality, tumor histology type, and the anatomic location of the lesion, we asked: (1) What is the cumulative incidence of femoral stem revision and stem complication in patients treated with cemented and uncemented hip arthroplasty for proximal femoral metastatic bone disease? (2) Are perioperative radiation and uncemented fixation independently associated with stem complication?<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Between January 2011 and December 2022, six centers performed 337 primary hip arthroplasties (THA or hemiarthroplasty) for proximal femoral metastatic bone disease. While these relative indications for fixation technique varied by center and surgeon, cemented fixation was used in some centers exclusively; where used selectively, it was generally used more frequently in older patients (&gt; 65 years), any patient with poorer radiographic proximal femoral bone quality, or in the setting of pathologic fractures and\/or lesions requiring intralesional resection rather than complete resection. Uncemented fixation was often selectively used in younger patients (&lt; 65 years) with adequate radiographic proximal femoral bone quality and often for lesions where all macroscopically visible disease was removed with sufficient remaining bone to accept uncemented fixation. A total of 287 cemented reconstructions (of which 19% [55 of 287] were THAs and 81% [232 of 287] were hemiarthroplasties) and 50 uncemented reconstructions (of which 50% [25 of 50] were THAs and 50% [25 of 50] were hemiarthroplasties) were performed. A total of 66% (190 of 287) and 36% (18 of 50) of patients, respectively, had died before 2 years, and 21% (61 of 287) and 42% (21 of 50), respectively, were lost to follow-up before 2 years but were not known to have died. As expected, the groups were substantially different at baseline, with the uncemented group being younger, less likely to have had a pathologic fracture, more likely to have received attempted wide resection rather than intralesional resection, more likely to have received this fixation technique at certain centers, and more likely to have received a THA, indicating a generally better preoperative functional status. Because of those substantial baseline differences between the fixation groups, we did not compare them but rather will report each separately in terms of survivorship with respect to stem revision and stem complication and factors associated with stem complication in this retrospective study. Those lost before 2 years were included if they reached a study endpoint before being lost. Patients who underwent a resection of the proximal femur and proximal femoral replacement were not included. Femoral stem revision was defined as any femoral reoperation including femoral stem revision, femoral stem explant with or without spacer, fixation around the stem, and head-liner exchange for infection or dislocation. A stem complication was defined as aseptic loosening, periprosthetic fracture around the stem, stem breakage or fracture of the implant, or tumor recurrence around the stem. A patient with a stem complication did not have to undergo a reoperation to be included. Competing risk analysis was performed to estimate cumulative incidence (95% confidence interval [95% CI]) of femoral stem revision and stem complication, with death as a competing risk. Logistic regression assessed whether radiation or uncemented fixation were independently associated with stem complication when controlling for each other.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In all patients, the cumulative incidence (considering death as a competing risk) of femoral stem revision at 2 years in the uncemented group was 4.4% (95% CI 0.8% to 13.6%) and 1.5% (95% CI 0.5% to 3.5%) in the cemented group. The cumulative incidence of stem complication at 2 years in the uncemented group was 2.0% (95% CI 0.2% to 9.4%) and 5.2% (95% CI 3.0% to 8.4%) in the cemented group. In patients who received radiation, the cumulative incidence (considering death as a competing risk) of femoral stem revision at 2 years in the uncemented group was 0% and 3.3% (95% CI 1.1% to 7.8%) in the cemented group. The cumulative incidence of stem complication at 2 years in the uncemented group was 0% and 7.8% (95% CI 3.8% to 13.6%) in the cemented group. We did not compare the groups statistically because they were so dissimilar at baseline. The percentage of patients who underwent femoral stem revision for periprosthetic fracture in the uncemented group was 2% (1 of 50) and 2% (6 of 287) in the cemented group. The percentage of patients who developed an inpatient venous thromboembolism in the uncemented group was 0% and 2.8% (8 of 287) in the cemented group; there was one patient with bone cement implantation syndrome in the cemented group. When controlling for each other, radiation (OR 1.6 [95% CI 0.7 to 3.9]; p = 0.30) and uncemented fixation (OR 0.2 [95% CI 0.01 to 1.2]; p = 0.17) were not independently associated with stem complication.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Because of substantial baseline differences between our study groups (which reflect careful patient selection), we cannot say whether uncemented stems are equivalent to or superior to cemented stems. Fixation choice remains multifactorial based on patient age, bone quality, tumor histology, and the anatomic location of the lesion. These data suggest that cemented fixation remains a reliable option for all patients. However, this study found that for well-selected patients\u2014generally those who were younger (&lt; 65 years) with adequate radiographic proximal femoral bone quality and with lesions where all macroscopically visible disease was removed with sufficient remaining bone to accept uncemented fixation\u2014uncemented stems can be a reasonable choice regardless of radiation status. Future comparative studies should focus on that subgroup of patients to see whether there are any specific advantages to uncemented reconstruction, such as shorter operative time, less physiologic stress of cement, and the chance for osseointegration, and if there are, whether those advantages come with any important tradeoffs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Level of Evidence<\/jats:title>\n            <jats:p>Level III, therapeutic study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/corr.0000000000003541","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T11:00:16Z","timestamp":1750071616000},"page":"1652-1664","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["What Is the Cumulative Incidence of Femoral Stem Revision and Stem Complication in Cemented and Uncemented Hip Arthroplasty for Proximal Femoral Metastatic Bone Disease?"],"prefix":"10.1097","volume":"483","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4069-7044","authenticated-orcid":false,"given":"Joshua M.","family":"Lawrenz","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1029-7015","authenticated-orcid":false,"given":"Stephen W.","family":"Chenard","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan P.","family":"Winter","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8709-4773","authenticated-orcid":false,"given":"Dana G.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer M.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8354-6540","authenticated-orcid":false,"given":"Benjamin M.","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Moffitt Cancer Center, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Eckhoff","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakmook","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0704-1529","authenticated-orcid":false,"given":"Alexander L.","family":"Lazarides","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Moffitt Cancer Center, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-5393","authenticated-orcid":false,"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia D.","family":"Visgauss","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-4290","authenticated-orcid":false,"given":"Christopher D.","family":"Collier","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-2680","authenticated-orcid":false,"given":"Lukas M.","family":"Nystrom","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Multicenter Orthopaedic Tumor Research (MORTaR) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"R1-20250827","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.3390\/curroncol28050320","article-title":"The surgical management of proximal femoral metastases: a narrative review","volume":"28","author":"Axelrod","year":"2021","journal-title":"Curr Oncol"},{"key":"R2-20250827","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1302\/0301-620X.100B8.BJJ-2017-1593.R1","article-title":"A randomized controlled trial of cemented versus cementless arthroplasty in patients with a displaced femoral neck fracture: a four-year follow-up","volume":"100-B","author":"Barenius","year":"2018","journal-title":"Bone Joint J"},{"key":"R3-20250827","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/8756-3282(93)90146-2","article-title":"Structural and cellular assessment of bone quality of proximal femur","volume":"14","author":"Dorr","year":"1993","journal-title":"Bone"},{"key":"R4-20250827","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa2108337","article-title":"Cemented or uncemented hemiarthroplasty for intracapsular hip fracture","volume":"386","author":"Fernandez","year":"2022","journal-title":"N Engl J Med"},{"key":"R5-20250827","doi-asserted-by":"crossref","first-page":"1083524","DOI":"10.3389\/fonc.2022.1083524","article-title":"Editorial: Impact of immunotherapy in lung cancer","volume":"12","author":"Ferreira","year":"2022","journal-title":"Front Oncol"},{"key":"R6-20250827","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.arth.2021.06.029","article-title":"Cemented vs cementless femoral fixation for total hip arthroplasty after displaced femoral neck fracture: a nationwide analysis of short-term complications and readmission rates","volume":"36","author":"Heckmann","year":"2021","journal-title":"J Arthroplasty"},{"key":"R7-20250827","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1097\/CORR.0000000000001932","article-title":"Cementless fixation is associated with increased risk of early and all-time revision after hemiarthroplasty but not after THA for femoral neck fracture: results from the American Joint Replacement Registry","volume":"479","author":"Huddleston","year":"2021","journal-title":"Clin Orthop Relat Res"},{"key":"R8-20250827","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1016\/j.arth.2023.04.039","article-title":"Cemented femoral fixation in total hip arthroplasty reduces the risk of periprosthetic femur fracture in patients 65 years and older: an analysis from the American Joint Replacement Registry","volume":"38","author":"Kelly","year":"2023","journal-title":"J Arthroplasty"},{"key":"R9-20250827","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2106\/00004623-200704000-00015","article-title":"Uncemented total hip arthroplasty in patients with a history of pelvic irradiation for prostate cancer","volume":"89","author":"Kim","year":"2007","journal-title":"J Bone Joint Surg Am."},{"key":"R10-20250827","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jor.2020.04.022","article-title":"Outcomes of press-fit uncemented versus cemented hip arthroplasty in the oncologic patient","volume":"22","author":"Larsen","year":"2020","journal-title":"J Orthop"},{"key":"R11-20250827","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/clr.12116","article-title":"Dose-dependent effect of radiation on titanium implants: a quantitative study in rabbits","volume":"25","author":"Li","year":"2014","journal-title":"Clin Oral Implants Res"},{"key":"R12-20250827","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","article-title":"Palliative radiation therapy for bone metastases: update of an ASTRO Evidence-Based Guideline","volume":"7","author":"Lutz","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"R13-20250827","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.otsr.2020.05.007","article-title":"Surgical management of proximal femoral metastasis: fixation or hip replacement? A 309 case series","volume":"106","author":"Meynard","year":"2020","journal-title":"Orthop Traumatol Surg Res"},{"key":"R14-20250827","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/jama.2020.1067","article-title":"Association between uncemented vs cemented hemiarthroplasty and revision surgery among patients with hip fracture","volume":"323","author":"Okike","year":"2020","journal-title":"JAMA"},{"key":"R15-20250827","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1016\/j.arth.2018.06.012","article-title":"Treatment modalities for pathologic fractures of the proximal femur pertrochanteric region: a systematic review and meta-analysis of reoperation rates","volume":"33","author":"Putnam","year":"2018","journal-title":"J Arthroplasty"},{"key":"R16-20250827","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/CORR.0000000000001541","article-title":"What are the frequency, related mortality, and factors associated with bone cement implantation syndrome in arthroplasty surgery?","volume":"479","author":"Rassir","year":"2021","journal-title":"Clin Orthop Relat Res"},{"key":"R17-20250827","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jbo.2018.02.006","article-title":"No consensus on implant choice for oligometastatic disease of the femoral head and neck","volume":"12","author":"Reif","year":"2018","journal-title":"J Bone Oncol"},{"key":"R18-20250827","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.arth.2012.03.036","article-title":"Uncemented arthroplasty for metastatic disease of the hip: preliminary clinical experience","volume":"27","author":"Thein","year":"2012","journal-title":"J Arthroplasty"},{"key":"R19-20250827","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1302\/0301-620X.104B1.BJJ-2021-0523.R1","article-title":"Risk of mortality and reoperation in hip fracture patients undergoing cemented versus uncemented hemiarthroplasty: a population-based study from Danish National Registries","volume":"104-B","author":"Viberg","year":"2022","journal-title":"Bone Joint J"},{"key":"R20-20250827","doi-asserted-by":"crossref","first-page":"101296","DOI":"10.1016\/j.artd.2023.101296","article-title":"Does perioperative radiation affect implant survivorship of primary total hip arthroplasty in the setting of metastatic bone disease?","volume":"25","author":"Vijayakumar","year":"2024","journal-title":"Arthroplast Today"},{"key":"R21-20250827","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12306-019-00597-z","article-title":"Systematic review of the outcome of cemented versus uncemented total hip arthroplasty following pelvic irradiation","volume":"103","author":"Walters","year":"2019","journal-title":"Musculoskelet Surg."}],"container-title":["Clinical Orthopaedics &amp; Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CORR.0000000000003541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:00:54Z","timestamp":1756324854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CORR.0000000000003541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/corr.0000000000003541","relation":{},"ISSN":["0009-921X","1528-1132"],"issn-type":[{"value":"0009-921X","type":"print"},{"value":"1528-1132","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"2025-01-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}